These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 29121666

  • 1. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    Richtig G, Aigelsreiter A, Schwarzenbacher D, Ress AL, Adiprasito JB, Stiegelbauer V, Hoefler G, Schauer S, Kiesslich T, Kornprat P, Winder T, Eisner F, Gerger A, Stoeger H, Stauber R, Lackner C, Pichler M.
    PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
    [Abstract] [Full Text] [Related]

  • 2. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T, Yasuchika K, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Komori J, Hatano E, Kawaguchi Y, Uemoto S.
    Sci Rep; 2016 Jul 26; 6():30489. PubMed ID: 27457505
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
    Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu C, Zou L, Li Z, Zhao J, Lin N.
    FEBS Lett; 2012 Dec 14; 586(24):4362-70. PubMed ID: 23178713
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
    Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C.
    Cancer Lett; 2019 Mar 01; 444():175-187. PubMed ID: 30448543
    [Abstract] [Full Text] [Related]

  • 5. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B, Liu D, Yang P, Li HY, Wang D.
    Gene; 2019 Jul 30; 707():78-85. PubMed ID: 31075412
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.
    Dig Dis Sci; 2017 Jan 30; 62(1):133-142. PubMed ID: 27921263
    [Abstract] [Full Text] [Related]

  • 7. The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma.
    Osman NAA, Khalil AI, Yousef RK.
    Asian Pac J Cancer Prev; 2020 Oct 01; 21(10):2961-2970. PubMed ID: 33112555
    [Abstract] [Full Text] [Related]

  • 8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.
    BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879
    [Abstract] [Full Text] [Related]

  • 10. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.
    Ma XL, Hu B, Tang WG, Xie SH, Ren N, Guo L, Lu RQ.
    J Hematol Oncol; 2020 Feb 05; 13(1):11. PubMed ID: 32024555
    [Abstract] [Full Text] [Related]

  • 11. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K, Yamashita T, Okada H, Kondo M, Hayashi T, Hara Y, Nomura Y, Zeng SS, Yoshida M, Hayashi T, Sunagozaka H, Oishi N, Honda M, Kaneko S.
    J Hepatol; 2015 Nov 05; 63(5):1164-72. PubMed ID: 26095183
    [Abstract] [Full Text] [Related]

  • 12. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
    Gao HJ, Zhao MC, Zhang YJ, Zhou DS, Xu L, Li GB, Chen MS, Liu J.
    J Cancer Res Clin Oncol; 2015 Jul 05; 141(7):1151-62. PubMed ID: 25446815
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hirata H, Sugimachi K, Takahashi Y, Ueda M, Sakimura S, Uchi R, Kurashige J, Takano Y, Nanbara S, Komatsu H, Saito T, Shinden Y, Iguchi T, Eguchi H, Atsumi K, Sakamoto K, Doi T, Hirakawa M, Honda H, Mimori K.
    Ann Surg Oncol; 2015 Dec 05; 22 Suppl 3():S1402-9. PubMed ID: 25404478
    [Abstract] [Full Text] [Related]

  • 14. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma.
    Liu C, Liu L, Chen X, Cheng J, Zhang H, Shen J, Shan J, Xu Y, Yang Z, Lai M, Qian C.
    Hepatology; 2016 Jul 05; 64(1):117-29. PubMed ID: 26910875
    [Abstract] [Full Text] [Related]

  • 15. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.
    Oncotarget; 2015 Dec 01; 6(38):41383-97. PubMed ID: 26515591
    [Abstract] [Full Text] [Related]

  • 16. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
    Leung CO, Mak WN, Kai AK, Chan KS, Lee TK, Ng IO, Lo RC.
    Oncotarget; 2016 May 17; 7(20):29371-86. PubMed ID: 27105493
    [Abstract] [Full Text] [Related]

  • 17. Incomplete radiofrequency ablation promotes the development of CD133+ cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression.
    Yuan CW, Wang ZC, Liu K, Liu DJ.
    Hepatobiliary Pancreat Dis Int; 2018 Oct 17; 17(5):416-422. PubMed ID: 30262419
    [Abstract] [Full Text] [Related]

  • 18. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.
    Désert R, Mebarki S, Desille M, Sicard M, Lavergne E, Renaud S, Bergeat D, Sulpice L, Perret C, Turlin B, Clément B, Musso O.
    Int J Biochem Cell Biol; 2016 Dec 17; 81(Pt A):195-207. PubMed ID: 27545991
    [Abstract] [Full Text] [Related]

  • 19. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
    Huang X, Cong X, Yang D, Ji L, Liu Y, Cui X, Cai J, He S, Zhu C, Ni R, Zhang Y.
    Pathol Res Pract; 2014 Nov 17; 210(11):719-25. PubMed ID: 25155751
    [Abstract] [Full Text] [Related]

  • 20. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 17; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.